Highly sensitive model for xenogenic GVHD using severe immunodeficient NOG mice

Area of Science:

• Immunology
• Transplantation Biology

Background:

• Established xenogenic graft versus host disease (xeno-GVHD) models in immunodeficient mice face challenges including the need for irradiation and large numbers of human peripheral blood mononuclear cells (hPBMCs).
• The timing of xeno-GVHD onset in existing models can be unstable, limiting their utility for research and drug development.

Purpose of the Study:

• To establish improved murine models for xeno-GVHD using novel immunodeficient NOD/Shi-scid IL2r gamma null (NOG) mice.
• To compare the efficacy of NOG mice against other immunodeficient strains in inducing xeno-GVHD.

Main Methods:

• Xenogenic graft versus host disease (xeno-GVHD) was induced in NOG, BALB/cA-RAG2 IL2r gamma null, and NOD/SCID mice by transplanting human peripheral blood mononuclear cells (hPBMCs).
• GVHD induction was performed with or without total body irradiation, and GVHD symptoms were compared across the different mouse strains.

Main Results:

• NOG mice demonstrated an earlier onset of GVHD symptoms following intravenous hPBMC transplantation compared to BALB/cA-RAG2 IL2r gamma null and NOD/SCID mice.
• A significantly smaller number of hPBMCs (2.5 x 10^6) was sufficient to induce GVHD in NOG mice.
• Total body irradiation was not consistently required for GVHD induction in the NOG mouse model.

Conclusions:

• The NOG mouse model provides a more efficient and sensitive system for studying xeno-GVHD.
• This improved model is a valuable tool for investigating GVHD mechanisms and for the development of novel therapeutic drugs for GVHD.